Potentially missing data are considerably more frequent than definitely missing data: a methodological survey of 638 randomized controlled trials

被引:6
|
作者
Kahale, Lara A. [1 ]
Diab, Batoul [1 ]
Khamis, Assem M. [1 ]
Chang, Yaping [2 ]
Lopes, Luciane Cruz [3 ]
Agarwal, Arnav [2 ,4 ]
Li, Ling [5 ,6 ]
Mustafa, Reem A. [2 ,7 ,8 ]
Koujanian, Serge [9 ]
Waziry, Reem [10 ]
Busse, Jason W. [2 ,11 ,12 ,13 ]
Dakik, Abeer [1 ]
Guyatt, Gordon [2 ,14 ]
Akl, Elie A. [1 ,2 ]
机构
[1] Amer Univ Beirut, Clin Epidemiol Unit, Beirut, Lebanon
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] Univ Sorocaba, UNISO, Pharmaceut Sci Post Grad Course, Sorocaba, SP, Brazil
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China
[6] Sichuan Univ, West China Hosp, CREAT Grp, Chengdu, Sichuan, Peoples R China
[7] Univ Missouri, Dept Med, Kansas City, MO 64110 USA
[8] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA
[9] Sunnybrook Hlth Sci Ctr, Dept Evaluat Clin Sci, Toronto, ON, Canada
[10] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA USA
[11] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada
[12] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada
[13] McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, Hamilton, ON, Canada
[14] McMaster Univ, Dept Med, Hamilton, ON, Canada
关键词
Missing data; Follow-up; Reporting; Risk of bias; Randomized controlled trials; Systematic reviews; Meta-analysis; OF-LIFE DATA; OUTCOME DATA; CLINICAL-TRIALS; METAANALYSIS; UNCERTAINTY; QUALITY; CHALLENGES; GUIDELINES; IMPUTATION; STATEMENT;
D O I
10.1016/j.jclinepi.2018.10.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: Missing data for the outcomes of participants in randomized controlled trials (RCTs) are a key element of risk of bias assessment. However, it is not always clear from RCT reports whether some categories of participants were followed-up or not (i.e., do or do not have missing data) nor how the RCT authors dealt with missing data in their analyses. Our objectives were to describe how RCT authors (1) report on different categories of participants that might have missing data, (2) handle these categories in the analysis, and (3) judge the risk of bias associated with missing data. Methods: We surveyed all RCT reports included in 100 clinical intervention systematic reviews (SRs), half of which were Cochrane SRs. Eligible SRs reported a group-level meta-analysis of a patient-important dichotomous efficacy outcome, with a statistically significant effect estimate. Eleven reviewers, working in pairs, independently extracted data from the primary RCT reports included in the SRs. We predefined 19 categories of participants that might have missing data. Then, we classified these participants as follows: "explicitly followed-up," "explicitly not followed-up" (i.e., definitely missing data), or "unclear follow-up status" (i.e., potentially missing data). Results: Of 638 eligible RCTs, 400 (63%) reported on at least one of the predefined categories of participants that might have missing data. The median percentage of participants who were explicitly not followed-up was 5.8% (interquartile range 2.2-14.8%); it was 9.7% (4.1-14.9%) for participants with unclear follow up status; and 11.7% (interquartile range 5.6-23.7%) for participants who were explicitly not followed-up and with unclear follow-up status. When authors explicitly reported not following-up participants, they most often conducted complete case analysis (54%). Most RCTs neither reported on missing data separately for different outcomes (99%) nor reported using a method for judging risk of bias associated with missing data (95%). Conclusion: "Potentially missing data" are considerably more frequent than "definitely missing data." Adequate reporting of missing data will require development of explicit standards on which editors insist and to which RCT authors adhere. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 31
页数:14
相关论文
共 50 条
  • [21] Methodological survey of missing outcome data in an alteplase for ischemic stroke meta-analysis
    Garg, Ravi
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 146 (03): : 252 - 257
  • [22] Covariate adjustment in randomized clinical trials with missing covariate and outcome data
    Chang, Chia-Rui
    Song, Yue
    Li, Fan
    Wang, Rui
    STATISTICS IN MEDICINE, 2023, 42 (22) : 3919 - 3935
  • [23] Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials
    Michalowsky, Bernhard
    Hoffmann, Wolfgang
    Kennedy, Kevin
    Xie, Feng
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (05) : 717 - 728
  • [24] Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials
    Bernhard Michalowsky
    Wolfgang Hoffmann
    Kevin Kennedy
    Feng Xie
    The European Journal of Health Economics, 2020, 21 : 717 - 728
  • [25] Missing data frequency and correlates in two randomized surgical trials for urinary incontinence in women
    Brubaker, Linda
    Litman, Heather J.
    Kim, Hae-Young
    Zimmern, Philippe
    Dyer, Keisha
    Kusek, John W.
    Richter, Holly E.
    Stoddard, Anne
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2015, 26 (08) : 1155 - 1159
  • [26] A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes
    Ibrahim, Fowzia
    Tom, Brian D. M.
    Scott, David L.
    Prevost, Andrew Toby
    TRIALS, 2016, 17
  • [27] The problem of missing data in randomized control trials A quick and easy guide
    Protopapas, A.
    Lambrinou, E.
    ARCHIVES OF HELLENIC MEDICINE, 2021, 38 (05): : 707 - 710
  • [28] Single time point comparisons in longitudinal randomized controlled trials: power and bias in the presence of missing data
    Erin L. Ashbeck
    Melanie L. Bell
    BMC Medical Research Methodology, 16
  • [29] A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data
    Tan, Ping-Tee
    Cro, Suzie
    Van Vogt, Eleanor
    Szigeti, Matyas
    Cornelius, Victoria R.
    BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [30] A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data
    Ping-Tee Tan
    Suzie Cro
    Eleanor Van Vogt
    Matyas Szigeti
    Victoria R. Cornelius
    BMC Medical Research Methodology, 21